Patents by Inventor John Jin Lim

John Jin Lim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240228443
    Abstract: The present disclosure relates to a manufacturing process for daprodustat in which the level of an acyl impurity of Formula (II) is kept below 0.15% w/w in isolated daprodustat drug substance. Immediate release formulations of daprodustat containing a composition of daprodustat in which the level of the acyl impurity of Formula (II) is kept below 0.15% w/w relative to daprodustat drug substance are also disclosed. Medical uses of the immediate release formulation and dosage regimens are disclosed.
    Type: Application
    Filed: June 18, 2021
    Publication date: July 11, 2024
    Inventors: Nicholas FLACO, Qiang GUO, John Jin LIM, Kathryn Renee MEINTEL, Alexander Gordon O'BRIEN
  • Patent number: 7393873
    Abstract: N-aryl arylsulfonamide derivatives are bradykinin B1 antagonists or inverse agonists useful in the treatment or prevention of symptoms such as pain and inflammation associated with the bradykinin B1 pathway.
    Type: Grant
    Filed: June 30, 2004
    Date of Patent: July 1, 2008
    Assignee: Merck & Co., Inc.
    Inventors: Neville J. Anthony, John Jin Lim, Dai-shi Su, Michael R. Wood
  • Patent number: 7332499
    Abstract: N-(Sulfonyloxybiarylmethyl) aminocyclopropanecarboxamide derivatives are bradykinin B1 antagonists or inverse agonists useful in the treatment or prevention of symptoms such as pain and inflammation associated with the bradykinin B1 pathway.
    Type: Grant
    Filed: August 3, 2004
    Date of Patent: February 19, 2008
    Assignee: Merck & Co., Inc.
    Inventors: Neville J. Anthony, Robert Gomez, Samson M. Jolly, John Jin Lim, Dai-shi Su